Optos

Optos is a prominent medical technology company established in 1992, specializing in the design, development, manufacturing, and marketing of ultra-widefield (UWF) retinal imaging devices. Operating within the Medical Devices & Equipment and Manufacturing sectors, Optos provides critical tools for the screening and diagnosis of a wide array of ocular conditions. These conditions include retinal detachment, glaucoma, cataracts, retinal holes/tears, and age-related macular degeneration. Furthermore, their technology aids in identifying indicators of non-eye diseases such as diabetes, hypertension, and certain cancers, underscoring its broad diagnostic utility.

The company's core product offerings revolve around advanced imaging technology, specifically retinal imaging devices and associated image management solutions. With a revenue of $135.8M and an employee range of 500-1,000 individuals, Optos demonstrates significant operational scale. The company maintains a presence across 12 locations globally, facilitating its reach and service capabilities. Its commitment to innovation in medical imaging technology positions it as a key player in diagnostic healthcare solutions.

Optos competes in a dynamic market alongside entities like Bausch & Lomb, Newmedica, and OCL Vision, focusing on delivering specialized medical devices. The company's strategic emphasis on UWF retinal imaging addresses a critical need for early detection and comprehensive patient care. Understanding the team behind such specialized technology is crucial for assessing operational expertise and future direction. Meet Optos's team to gain insights into the leadership and personnel driving Optos's advancements in medical technology.